An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
about
Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine.Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain?Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models.Q58736005
P2860
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
@en
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
@nl
type
label
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
@en
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
@nl
prefLabel
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
@en
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer
@en
P2093
Alberto Vides
Elisa de Stanchina
Fabiola Cechhi
Greg J Riely
Jonas Nilsson
Jorge S Reis-Filho
Kalyani Chadalavada
Kerry Scott
Martha Solomon
P2860
P2888
P304
P356
10.1038/NM.4369
P407
P577
2017-07-17T00:00:00Z